Ibacitabine
|
WikiDoc Resources for Ibacitabine |
|
Articles |
|---|
|
Most recent articles on Ibacitabine Most cited articles on Ibacitabine |
|
Media |
|
Powerpoint slides on Ibacitabine |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Ibacitabine at Clinical Trials.gov Clinical Trials on Ibacitabine at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Ibacitabine
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Ibacitabine Discussion groups on Ibacitabine Patient Handouts on Ibacitabine Directions to Hospitals Treating Ibacitabine Risk calculators and risk factors for Ibacitabine
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Ibacitabine |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Ibacitabine (or ibacitabin,[1] or 5-iodo-2'-deoxycytidine ) is an antiviral drug.
References
External links